Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS

While hypertension and inflammation are physiologically inter-related, the effect of therapies that specifically target inflammation on blood pressure is uncertain. The recent CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) afforded the opportunity to test whether IL (interleukin)-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothman, Alexander MK, MacFadyen, Jean, Thuren, Tom, Webb, Alastair, Harrison, David G, Guzik, Tomasz J., Libby, Peter, Glynn, Robert J., Ridker, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott, Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055941/
https://www.ncbi.nlm.nih.gov/pubmed/31884854
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.13642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055941/
https://www.ncbi.nlm.nih.gov/pubmed/31884854
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.13642

Ejemplares similares